1. Home
  2. ENLT vs TWST Comparison

ENLT vs TWST Comparison

Compare ENLT & TWST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Enlight Renewable Energy Ltd.

ENLT

Enlight Renewable Energy Ltd.

HOLD

Current Price

$68.77

Market Cap

9.6B

Sector

N/A

ML Signal

HOLD

Logo Twist Bioscience Corporation

TWST

Twist Bioscience Corporation

HOLD

Current Price

$179.82

Market Cap

9.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ENLT
TWST
Founded
2008
2013
Country
Israel
United States
Employees
406
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.6B
9.2B
IPO Year
2022
2018

Fundamental Metrics

Financial Performance
Metric
ENLT
TWST
Price
$68.77
$179.82
Analyst Decision
Buy
Buy
Analyst Count
6
8
Target Price
★ $48.83
$46.88
AVG Volume (30 Days)
142.8K
★ 1.8M
Earning Date
05-05-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 63.89
EPS
★ N/A
N/A
Revenue
N/A
★ $376,572,000.00
Revenue This Year
$403.69
$18.91
Revenue Next Year
N/A
$15.07
P/E Ratio
$76.10
★ N/A
Revenue Growth
N/A
★ 20.32
52 Week Low
$29.65
$23.30
52 Week High
$108.65
$186.20

Technical Indicators

Market Signals
Indicator
ENLT
TWST
Relative Strength Index (RSI) 35.48 70.26
Support Level $65.61 $41.18
Resistance Level $78.17 N/A
Average True Range (ATR) 1.72 11.17
MACD -0.25 3.45
Stochastic Oscillator 7.16 87.21

Price Performance

Historical Comparison
ENLT
TWST

About ENLT Enlight Renewable Energy Ltd.

Enlight Renewable Energy Ltd develops, finances, constructs, owns, and operates utility-scale renewable energy projects. The company's operating segments are the MENA segment, Europe segment, U.S.A segment, and Others. It generates the majority of its revenue from the Europe segment, producing its revenue from the sale of the electricity which is produced through wind energy and solar energy in Europe.

About TWST Twist Bioscience Corporation

Twist Bioscience Corp is a synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's proprietary semiconductor-based manufacturing process synthesizes DNA on silicon rather than traditional plastic plates, enabling the production of high-quality synthetic DNA faster, more affordably, and at scale. This platform overcomes conventional inefficiencies, supports cost-effective, high-throughput synthesis, and allows researchers to accelerate innovation. Geographically, the company operates across the Americas, EMEA, and APAC, deriving the majority of its revenue from the Americas.

Share on Social Networks: